Daniela Reich-Erkelenz Selected Research

Disease Progression

1/2013

Assessment of Response to Lithium Maintenance Treatment in Bipolar Disorder: A Consortium on Lithium Genetics (ConLiGen) Report.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Daniela Reich-Erkelenz Research Topics

Disease

8	Bipolar Disorder (Manic Depressive Psychosis) 02/2024 - 01/2013
4	Mental Disorders (Mental Disorder) 02/2023 - 01/2022
1	Schizophrenia (Dementia Praecox) 01/2023
1	Major Depressive Disorder (Major Depressive Disorders) 01/2023
1	Substance-Related Disorders (Drug Abuse) 01/2021
1	Psychotic Disorders (Schizoaffective Disorder) 01/2020
1	Genetic Risk Score 01/2019
1	Disease Progression 01/2013

Drug/Important Bio-Agent (IBA)

8	LithiumIBA 02/2024 - 01/2013
2	Cholinergic Agents (Cholinergics)IBA 07/2023 - 02/2023
1	LipidsIBA 01/2023
1	Proteins (Proteins, Gene)FDA Link 01/2023
1	Antipsychotic Agents (Antipsychotics)IBA 01/2021
1	Genetic Markers (Genetic Marker)IBA 01/2020
1	MicroRNAs (MicroRNA)IBA 01/2018
1	Biomarkers (Surrogate Marker)IBA 03/2016

Therapy/Procedure

1	Precision Medicine 01/2022